Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients
This study is currently recruiting participants.
Verified March 2013
by Grifols Therapeutics Inc.
Study NCT01014975 Information provided by Grifols Therapeutics Inc.
First Received on November 16, 2009. Last Updated on March 11, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Ischemic Stroke
Additional conditions recognized in this trial
More general conditions related to this trial
Central Nervous System Diseases
Nervous System Diseases
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Grifols Therapeutics Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers